ABERRANT P16 METHYLATION, A POSSIBLE EPIGENETIC RISK FACTOR IN FAMILIAL ESOPHAGEAL SQUAMOUS CELL CARCINOMA

ABBASZADEGAN, M.R., RAZIEI, H.R., GHAFARZADEGAN, KAMRAN, SHAKERI, M.T., GHAVAM NASIRI, M.R., & AFSHARNEZHAD, S.. (2005). ABERRANT P16 METHYLATION, A POSSIBLE EPIGENETIC RISK FACTOR IN FAMILIAL ESOPHAGEAL SQUAMOUS CELL CARCINOMA. INTERNATIONAL JOURNAL OF GASTROINTESTINAL CANCER, 36(1), 47-54. SID. https://sid.ir/paper/537752/en

ABBASZADEGAN M.R., RAZIEI H.R., GHAFARZADEGAN KAMRAN, SHAKERI M.T., GHAVAM NASIRI M.R., AFSHARNEZHAD S.. ABERRANT P16 METHYLATION, A POSSIBLE EPIGENETIC RISK FACTOR IN FAMILIAL ESOPHAGEAL SQUAMOUS CELL CARCINOMA. INTERNATIONAL JOURNAL OF GASTROINTESTINAL CANCER[Internet]. 2005;36(1):47-54. Available from: https://sid.ir/paper/537752/en

M.R. ABBASZADEGAN, H.R. RAZIEI, KAMRAN GHAFARZADEGAN, M.T. SHAKERI, M.R. GHAVAM NASIRI, and S. AFSHARNEZHAD, “ABERRANT P16 METHYLATION, A POSSIBLE EPIGENETIC RISK FACTOR IN FAMILIAL ESOPHAGEAL SQUAMOUS CELL CARCINOMA,” INTERNATIONAL JOURNAL OF GASTROINTESTINAL CANCER, vol. 36, no. 1, pp. 47–54, 2005, [Online]. Available: https://sid.ir/paper/537752/en